#Japan #veterinary services #Pet Healthcare #Setagaya #12 Pharmacy

12 Pharmacy Completes Second Close of Series A Funding

In a significant milestone for veterinary services, 12 Pharmacy, a company specializing in pharmaceutical solutions for animal hospitals, has announced the successful completion of the second close in its Series A funding round. Based in Setagaya, Tokyo, 12 Pharmacy has managed to meet its fundraising target with the additional participation of three investors: ARKRAY & PARTNERS Pte. Ltd., Beta Venture Capital, and FFG Venture Business Partners, continuing to enhance its capabilities in veterinary medicine.

About 12 Pharmacy

12 Pharmacy operates a unique online prescription system designed to streamline the process of filling prescriptions for animal hospitals. With a dedicated team of specialized pharmacists, the company ensures that medications prescribed by veterinarians are delivered directly to pet owners’ homes, making the process convenient and efficient.

Challenges in Veterinary Medicine

The demand for 12 Pharmacy's services is primarily driven by the various challenges faced by animal hospitals, including staff shortages and burdens related to inventory management. As these issues compound, the need for professional pharmaceutical services becomes more pressing. With its recent funding success, 12 Pharmacy aims to build further upon its existing services, thus alleviating the workload for veterinary professionals and enhancing the overall health care experience for pets and their owners.

Investor Insights

Yohei Onigata, ARKRAY & PARTNERS Pte. Ltd.

“At ARKRAY, we have always focused on animal health through our exclusive brand ‘thinka (think animal)’. The vision and driving force behind 12 Pharmacy’s commitment to high-quality pharmaceuticals and service is truly inspiring. By introducing external pharmacy options into the animal healthcare sector, we expect to create an environment where veterinarians can focus more on their practices and treatments, leading to an overall better quality of animal medical care. We are dedicated to supporting 12 Pharmacy’s growth through our startup support program, ARKRAY 4U, leveraging both financial and resource-based assistance.”

Taro Akase, Beta Venture Capital

“We have increased our investment following our initial funding last year, witnessing a growing expectation from animal hospitals towards our services. Each hospital is unique in its scale and specialized fields, which presents varied challenges. While some facilities delegate all compounding to us, our service essentially allows each hospital to choose to outsource whenever they find it beneficial. Our goal is to empower these hospitals to focus on their most valuable tasks.”

Akira Ninomiya, FFG Venture Business Partners

“The sector has long been burdened with animal hospitals handling their own compounding roles, which takes away from their core mission of patient care. This has resulted in numerous challenges, such as increased waiting times and staff strain. 12 Pharmacy proposes a new model that emphasizes a separation of roles between medical examination and pharmaceutical services, creating a sustainable solution beneficial to both practitioners and their clients. We are thrilled to invest in a team that not only has accumulated substantial knowledge in veterinary pharmaceuticals but also possesses the operational capability to realize these initiatives.”

Company Overview

Company Name: 12 Pharmacy Co., Ltd.

Headquarters: 6-33-36 Minami-Karasuyama, Setagaya-ku, Tokyo (Kanto Headquarters), 2-14 Sugawaramachi, Kita-ku, Osaka (Kansai Branch), 6-4 Genzaemon Shinden, Kawaguchi, Saitama (Animal General Hospital Front)

Telephone: 03-5314-1720

Business Focus: Operation of animal-specific pharmacies and provision of related veterinary services.

Website: 12 Pharmacy

The future looks bright for 12 Pharmacy as they leverage newly acquired resources to improve the landscape of veterinary healthcare, delivering both peace of mind and happiness to pet owners and their beloved furry companions.